Surgical Wound Clinical Trial
Official title:
The Use of Post-operative Negative Pressure Wound Therapy (NPWT) Dressing in the Prevention of Wound Healing Problems and Infectious Complications After Ostomy Reversal Surgery.
Verified date | September 2019 |
Source | Jagiellonian University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Introduction: Although negative-pressure wound therapy (NPWT) is likely advantageous for wound healing, the efficacy and safety of its prophylactic use remain unclear. We performed a Randomized Control Trial to assess the usefulness of postoperative NPWT in reduction of postoperative wound healing complications and surgical site infections after diverting ileostomy closure, in the group of patients previously operated for colorectal resection due to cancer. Materials & Methods: Prospective, randomized study will be conducted. Patients with past history of colorectal cancer laparoscopic surgery with protective loop ileostomy scheduled to undergo ileostomy closure with primary wound closure will be randomly divided into groups with or without NPWT. The primary endpoint are incidence of wound related complications (WRC) (wound healing complications witch required surgical intervention other than suture removal or dressing changing). The secondary endpoints are incidences of Surgical Site Infection (SSI) and length of postoperative hospital stay (LOS) and length of complete wound healing (CWH). Cost analysis will also be performed. In first step of this study between January 2016 and December 2018 we will asses the usefulness of one of the NPWT devices (NANOVA KCI) in prevention of WHC in established group. The second part of the study will be performed in 2 centers between January 2019 and December 2021. In this step we want to compere other NPWT devices in the same application and to confirm single center outcomes .
Status | Completed |
Enrollment | 70 |
Est. completion date | January 1, 2021 |
Est. primary completion date | January 1, 2021 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Patients aged 18 or older - Previous colorectal resection with the formation of protective ileostomy due to cancer - Ileostomy closure surgery as an elective procedure. Exclusion Criteria: - Emergency or urgent operation - Active infection - Other than ileostomy closure or parastomal hernioplasty operation performed. - Patents who within 1 week after operation will be re-operated or transferred to Intensive Care Unit or other hospital word due to noninfectious complications |
Country | Name | City | State |
---|---|---|---|
Poland | 2nd Department of General Surgery, Jagiellonian University | Kraków | |
Poland | Oddzial kliniczny chirurgii ogólnej, endokrynologicznej i onkologii gastroenterologicznej | Poznan | Wielkopolska |
Lead Sponsor | Collaborator |
---|---|
Michal Pedziwiatr |
Poland,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Incidence of wound management complications | Primary endpoint is described as a reduction of wound healing complications (WHC) after protective ostomy closure in a group of patients previously operated for colorectal cancer with protective ileostomy formation. Wound healing complications are described as any condition of wound which required postoperative intervention other than change of dressing or removing of sutures . | 90 days | |
Primary | Incidence of wound management complications in groups treated with different types of postopNPWT | The primary endpoint is described as a comparison of reduction of wound healing complications (WHC) after protective ostomy closure in a group of patients previously operated for colorectal cancer with protective ileostomy formation between 3 different postopNPWT devices (KCI NANOVA, Smith&Naphiew PICO and Gynadyne XLR 8) . Wound healing complications are described as any condition of wound which required postoperative intervention other than change of dressing or removing of sutures . | 90 days | |
Secondary | Surgical Site Infections (SSI) Incidence | Secondary endpoints is described as incidence of SSI. Incisional SSI diagnosis criteria included an infection that occurred within 30 days after the operation involving the skin, subcutaneous tissue, or deep soft tissue (e.g. fascia and muscle layers) at the incision site, organ or space according to the criteria of CDC and ECDC for diagnosis of SSI | 90 days | |
Secondary | Postoperative Hospital Stay (LOS) | Secondary endpoints is described as postoperative length of hospital stay (LOS) | 90 days | |
Secondary | Complete wound healing (CWH) time | Secondary endpoints is described as the duration of complete wound healing (CWH). Complete wound healing was defined as complete closure of the wound without any discharge at the outpatient clinic or reported by patient. | 90 Days |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04081792 -
Optimal Antibiotics for Operated Diabetic Foot Infections
|
N/A | |
Recruiting |
NCT02685761 -
Skin Incisions and Wound Complication Rates for C-sections in Obese Women
|
N/A | |
Completed |
NCT01297322 -
RESPECT Trial - (Rapid Extravascular Sealing Via PercutanEous Collagen ImplanT)
|
N/A | |
Not yet recruiting |
NCT03872544 -
Short Term Status of Free Dermal Fat Autografts for Complex Craniofacial Wounds
|
||
Completed |
NCT03193021 -
AMBULATE: Cardiva Mid-Bore VVCS vs. Manual Compression for Multiple Femoral Venous Access Sites, 6 - 12F ID
|
N/A | |
Not yet recruiting |
NCT06028854 -
Blood Characteristics and Abdominal Emergency Surgery
|
||
Completed |
NCT05646121 -
Suprasorb® A + Ag in the Treatment of Wounds at Risk of Infection and Infected Wounds
|
||
Enrolling by invitation |
NCT03880188 -
Long Term Status of Free Dermal Fat Autografts for Complex Craniofacial Wounds
|
||
Recruiting |
NCT06342479 -
Discharge Training for Patients With Intertrochanteric Fracture
|
N/A | |
Recruiting |
NCT03561376 -
Zinc Oxide Versus Petrolatum Following Skin Surgery
|
Early Phase 1 | |
Recruiting |
NCT04994145 -
A Post-Market Clinical Investigation on Mepilex Border Post-Op
|
||
Recruiting |
NCT04439552 -
fMRI and IVCM Cornea Microscopy of CXL in Keratoconus
|
||
Completed |
NCT05618912 -
Scar Appearance After Postoperative Hydrocolloid Dressing Versus Standard Petrolatum Ointment
|
N/A | |
Completed |
NCT04596163 -
Transversus Thoracis Muscle Plane Block for Sternotomy Pain in Cardiac Surgery
|
N/A | |
Completed |
NCT04036344 -
Buddy Relationships in DermatoloGic Excisions for Skin Cancer
|
N/A | |
Completed |
NCT05791721 -
Effect of Preemptive Etoricoxib and Dexamethasone on Wound Healing and Clinical Parameters After Third Molar Surgery
|
Phase 4 | |
Recruiting |
NCT06073678 -
Photobiomodulation in Palate Wounds: Somatosensorial Evaluation
|
N/A | |
Completed |
NCT05252260 -
Comparison of Diode Laser-Assisted Vestibuloplasty And Conventional Vestibuloplasty
|
N/A | |
Withdrawn |
NCT04053946 -
Clinical Assessment of Next Science Wound Gels in Healing Below the Knee Amputation Surgical Wound Compared to SOC
|
N/A | |
Recruiting |
NCT04740775 -
LiquiBand® Exceed™ and LiquiBand® Rapid™ for General Surgery Procedures
|
N/A |